For: | Javaeed A, Ghauri SK. Metastatic potential and prognostic significance of SOX2: A meta-analysis. World J Clin Oncol 2019; 10(6): 234-246 [PMID: 31367532 DOI: 10.5306/wjco.v10.i6.234] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v10/i6/234.htm |
Number | Citing Articles |
1 |
Sayantanee Chaudhury, Swagatika Panda, Neeta Mohanty, Saurav Panda, Diksha Mohapatra, Ravishankar Nagaraja, Alkananda Sahoo, Divya Gopinath, Natalia Lewkowicz, Barbara Lapinska. Can Immunoexpression of Cancer Stem Cell Markers Prognosticate Tongue Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2023; 12(8): 2753 doi: 10.3390/jcm12082753
|
2 |
Xian-hui Zhang, Wei Wang, Ya-qi Wang, Lei Zhu, Lan Ma. The association of SOX2 with clinical features and prognosis in colorectal cancer: A meta-analysis. Pathology - Research and Practice 2020; 216(1): 152769 doi: 10.1016/j.prp.2019.152769
|
3 |
Miriam Gross-Cohen, Yifat Yanku, Ofra Kessler, Uri Barash, Ilanit Boyango, Angel Cid-Arregui, Gera Neufeld, Neta Ilan, Israel Vlodavsky. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression. Matrix Biology 2021; 99: 58 doi: 10.1016/j.matbio.2021.05.001
|
4 |
Adriana G. Quiroz-Reyes, Paulina Delgado-Gonzalez, Jose Francisco Islas, Juan Luis Delgado Gallegos, Javier Humberto Martínez Garza, Elsa N. Garza-Treviño. Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL. Pharmaceutics 2021; 13(7): 1062 doi: 10.3390/pharmaceutics13071062
|
5 |
Gang Zhao, Xiaozhen Wang, Limei Qu, Zhu Zhu, Jinghui Hong, Haiqin Hou, Zuonong Li, Jun Wang, Zheng Lv. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis. Breast Care 2021; 16(1): 16 doi: 10.1159/000505806
|
6 |
Zahra Hosseini-khah, Mohammad Reza Babaei, Mohsen Tehrani, Magali Cucchiarini, Henning Madry, Abolghasem Ajami, Nasser Rakhshani, Alireza Rafiei, Behrooz Nikbin. SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Current Oncology 2021; 28(4): 3015 doi: 10.3390/curroncol28040264
|